Regulatory Status and Quality Considerations BPC-157 currently lacks approval from the United States Food and Drug Administration (FDA) or other major regulatory authorities for any therapeutic indication
Important Safety Information READ MORE LESS Scroll to Indication Important Safety Information Do not share your Ozempic pen with other people, even if the needle has been changed
A prospective randomized, double-blind, placebo-controlled, dose-response relationship study to investigate efficacy of fructo-oligosaccharides (FOS) on human gut microflora
Take 1 capsule daily with water, preferably on an empty stomach
This product is not evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease
Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes